Rohto Pharmaceutical Co Ltd
TSE:4527

Watchlist Manager
Rohto Pharmaceutical Co Ltd Logo
Rohto Pharmaceutical Co Ltd
TSE:4527
Watchlist
Price: 2 879.5 JPY -0.93%
Market Cap: 658.7B JPY
Have any thoughts about
Rohto Pharmaceutical Co Ltd?
Write Note

Rohto Pharmaceutical Co Ltd
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Rohto Pharmaceutical Co Ltd
Other Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
Rohto Pharmaceutical Co Ltd
TSE:4527
Other Equity
ÂĄ25.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shiseido Co Ltd
TSE:4911
Other Equity
ÂĄ155.4B
CAGR 3-Years
73%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kao Corp
TSE:4452
Other Equity
ÂĄ95.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kose Corp
TSE:4922
Other Equity
ÂĄ21.5B
CAGR 3-Years
66%
CAGR 5-Years
N/A
CAGR 10-Years
23%
F
Fancl Corp
TSE:4921
Other Equity
ÂĄ132m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
28%
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Other Equity
ÂĄ13.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Rohto Pharmaceutical Co Ltd
Glance View

Market Cap
656.9B JPY
Industry
Consumer products

Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. The company is headquartered in Osaka, Osaka-Fu and currently employs 6,596 full-time employees. The firm primarily provides eye care-related products, including eye drops and eye lotions; skin care-related products, including dermatological preparations, lip balms, sunscreens and functional cosmetics; oral medication and food-related products, including digestive medicines, Chinese herbal medicines and supplements, as well as extracorporeal test drugs and other products. The firm operates its business in domestic market and overseas markets, including Europe, Asia and America.

Intrinsic Value
3 347.52 JPY
Undervaluation 14%
Intrinsic Value
Price

See Also

What is Rohto Pharmaceutical Co Ltd's Other Equity?
Other Equity
25.3B JPY

Based on the financial report for Sep 30, 2024, Rohto Pharmaceutical Co Ltd's Other Equity amounts to 25.3B JPY.

What is Rohto Pharmaceutical Co Ltd's Other Equity growth rate?
Other Equity CAGR 1Y
43%

Over the last year, the Other Equity growth was 43%.

Back to Top